--- title: "Surgery Partners, Inc. (SGRY.US)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/SGRY.US.md" symbol: "SGRY.US" name: "Surgery Partners, Inc." industry: "医疗机构" --- # Surgery Partners, Inc. (SGRY.US) | Item | Detail | |------|--------| | Industry | 医疗机构 | | Location | 美股市场 | | Website | [www.surgerypartners.com](https://www.surgerypartners.com) | ## Company Profile Surgery Partners, Inc.及其子公司在美国拥有并运营一系列外科设施和辅助服务。该公司提供门诊手术中心和外科医院,提供各种专业领域的非紧急手术程序,包括骨科和疼痛管理、眼科、胃肠病学和普通外科。它提供急诊科;以及辅助服务,如多专业医生诊所、急救设施和麻醉服务。此外,它还提供单一和多专业设施 ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-02-20T04:30:12.000Z **Overall: C (0.59)** **Industry**: Health Care Facilities | Metric | Value | |--------|-------| | Industry Ranking | 14 / 25 | | Industry Median | C | | Industry Average | C | - **Style**: Value - Stocks where the company's main business is in a mature stage. - **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 10.14% | | | Net Profit YoY | -182.84% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | 1.15 | | | Dividend Ratio | 0.00% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 1.99B | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 3.29B | | **Multi Score**: C #### Profit Score: D | Indicator | Value | Rating | |-----------|-------|--------| | ROE | -9.45% | D | | Profit Margin | -5.21% | D | | Gross Margin | 23.77% | C | #### Growth Score: C | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 10.14% | B | | Net Profit YoY | -182.84% | E | | Total Assets YoY | 5.47% | B | | Net Assets YoY | 0.13% | C | #### Cash Score: D | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | -1918.38% | E | | OCF YoY | 10.14% | B | #### Operating Score: C | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 0.42 | C | #### Debt Score: C | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 55.29% | C | ```chart-data:radar { "title": "Longbridge Financial Score - Surgery Partners, Inc.", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "D", "indicators": [ { "name": "ROE", "value": "-9.45%", "rating": "D" }, { "name": "Profit Margin", "value": "-5.21%", "rating": "D" }, { "name": "Gross Margin", "value": "23.77%", "rating": "C" } ] }, { "name": "Growth", "grade": "C", "indicators": [ { "name": "Revenue YoY", "value": "10.14%", "rating": "B" }, { "name": "Net Profit YoY", "value": "-182.84%", "rating": "E" }, { "name": "Total Assets YoY", "value": "5.47%", "rating": "B" }, { "name": "Net Assets YoY", "value": "0.13%", "rating": "C" } ] }, { "name": "Cash", "grade": "D", "indicators": [ { "name": "Cash Flow Margin", "value": "-1918.38%", "rating": "E" }, { "name": "OCF YoY", "value": "10.14%", "rating": "B" } ] }, { "name": "Operating", "grade": "C", "indicators": [ { "name": "Turnover", "value": "0.42", "rating": "C" } ] }, { "name": "Security", "grade": "C", "indicators": [ { "name": "Gearing Ratio", "value": "55.29%", "rating": "C" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | 环球保健 (US.UHS) | B | B | A | C | B | B | | 02 | 恩赛因 (US.ENSG) | B | B | A | D | B | B | | 03 | Encompass Health (US.EHC) | A | B | B | C | B | B | | 04 | PACS (US.PACS) | B | A | A | E | A | B | | 05 | Concentra Group Holdings Parent (US.CON) | B | B | B | E | B | B | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | -11.58 | 17/23 | - | - | - | | PB | 1.15 | 5/23 | 1.67 | 1.59 | 1.19 | | PS (TTM) | 0.60 | 8/23 | 0.93 | 0.86 | 0.63 | | Dividend Yield | 0.00% | - | - | - | - | ## Institutional View ### Analyst Rating Distribution > As of 2025-12-18T05:00:00.000Z Total Analysts: **12** | Rating | Count | Percentage | |--------|-------|-----------| | Buy | 8 | 67% | | Overweight | 1 | 8% | | Hold | 3 | 25% | | Underweight | 0 | 0% | | Sell | 0 | 0% | ### Target Price Forecast | Metric | Price | |--------|-------| | Current Price | 15.54 | | Highest Target | 33.00 | | Lowest Target | 18.00 | ## References - [Company Overview](https://longbridge.com/en/quote/SGRY.US/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/SGRY.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/SGRY.US/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.